SKYE · CIK 0001516551 · operating
Skye Bioscience, Inc. (SKYE) is a pharmaceutical preparations company incorporated in NV, listed on the Nasdaq. With a market capitalization of $24 million, Skye Bioscience, Inc. is a micro-cap company. The stock currently trades at $0.77, up 2.98% today, with a 52-week range of $0.68–$5.75.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.73 | $-0.73 | +86.4% | |
| 2023 | $-5.37 | $-5.37 | -13325.0% | |
| 2022 | $-0.04 | $-0.04 | -100.0% | |
| 2021 | $-0.02 | $-0.02 | +33.3% | |
| 2020 | $-0.03 | $-0.03 | +40.0% | |
| 2019 | $-0.05 | $0.01 | — | |
| 2018 | — | — | — | |
| 2017 | $-0.11 | $-0.11 | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-20 | 0001516551-25-000027 | SEC ↗ |
| 2023-12-31 | 2024-03-22 | 0001516551-24-000048 | SEC ↗ |
| 2022-12-31 | 2023-03-31 | 0001516551-23-000038 | SEC ↗ |
| 2021-12-31 | 2022-03-28 | 0001516551-22-000004 | SEC ↗ |
| 2020-12-31 | 2021-03-02 | 0001640334-21-000483 | SEC ↗ |
| 2019-12-31 | 2020-03-23 | 0001640334-20-000582 | SEC ↗ |
| 2018-12-31 | 2019-03-14 | 0001640334-19-000379 | SEC ↗ |
| 2017-12-31 | 2018-03-19 | 0001640334-18-000482 | SEC ↗ |
| 2016-12-31 | 2017-03-10 | 0001640334-17-000456 | SEC ↗ |
| 2015-12-31 | 2016-03-21 | 0001640334-16-000847 | SEC ↗ |
| 2014-12-31 | 2015-03-27 | 0001557240-15-000195 | SEC ↗ |
| 2013-10-31 | 2014-01-27 | 0001557240-14-000036 | SEC ↗ |